Big Pharma, Big Bucks (Part 3)

How pharmaceutical companies increasingly engage in “disease mongering” — that is, promoting health conditions themselves for the purpose of medicalizing normal conditions of everyday life (e.g., “adult ADD” and “social anxiety disorder”) and normalzing relatively obscure conditions to create the false impression they’re common (e.g., “restless leg syndrome”).